Aptevo Therapeutics (APVO) Tops Q1 EPS by 161c
Get Alerts APVO Hot Sheet
Join SI Premium – FREE
Aptevo Therapeutics (NASDAQ: APVO) reported Q1 EPS of $0.26, $1.61 better than the analyst estimate of ($1.35).
For earnings history and earnings-related data on Aptevo Therapeutics (APVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Ocean Power Technologies revises fiscal 2026 results after audit
- Jaguar Health (JAGX) Tops Q2 EPS by 3647c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share